Sagent Pharmaceuticals data breach

Clerk's notes

Sagent Pharmaceuticals filed a notice regarding a data incident that occurred on February 11, 2026. The company formally reported this event on April 17, 2026. This filing indicates that some personal information entrusted to Sagent Pharmaceuticals may have been accessed without authorization.

While the specific types of personal information involved have not been detailed, the breach notification suggests that individuals' data was affected. Sagent Pharmaceuticals has stated that the incident is currently under investigation to determine its full scope and impact. This process aims to identify exactly what occurred and which data elements were compromised.

If you received a data breach notification letter from Sagent Pharmaceuticals, it means your personal information was part of this incident. It is advisable to carefully review the letter for any specific guidance provided by the company. Remaining vigilant for any unusual activity related to your accounts is a general best practice after such an event.

Understanding the implications of a data incident can be complex, especially when details are still emerging. Individuals affected by the Sagent Pharmaceuticals data breach may wish to seek a free, no-obligation case review. This step can help clarify the situation and explore potential next actions tailored to your circumstances, without promising specific outcomes.

If a notification letter about this breach reached you, see every IN data breach on file or browse all cases.